Please Note: Microsoft has ended support of its older browsers as of January 2016. If you are seeing this message, you are viewing the site on an unsupported version of Internet Explorer (IE10 or older). To properly view this website, please upgrade your version of IE or access this site using a different browser. Thank you.
Sign InDues Join Privacy Contact Search
Home News Scrip

Scrip

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below.

John Lezcano
Corporate Account Manager
M: (631) 807-4971
John.lezcano@informa.com

Pharma intelligence | informa
P: (212) 652-2678
pharmaintelligence.informa.com

Scrip
Friday, December 4, 2020
The US is to ship only half of doses for Pfizer, Moderna COVID-19 vaccines in the first instance, while Rhizen Pharmaceuticals...
Friday, December 4, 2020
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up...
Thursday, December 3, 2020
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in...
Thursday, December 3, 2020
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew...
Thursday, December 3, 2020
Plus deals involving LegoChem/Pyxix, Biohaven/Sosei Heptares, Kyowa Kirin/Helsinn, Dr. Reddy’s/Glenmark, Eisai/Wren, KoBioLabs/Kolmar Korea, Y-Biologics/Pierre Fabre, Generex/Chinese consortium.
Thursday, December 3, 2020
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19...
Thursday, December 3, 2020
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full...
Thursday, December 3, 2020
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer/BioNTech's COVID-19 vaccine in 2021 and beyond.  ...
Thursday, December 3, 2020
Regulatory pressure to fully approve the first COVID-19 vaccine in China is mounting as top officials tour an inspection agency...
Thursday, December 3, 2020
Helped by a hefty financing earlier this year, Bukwang subsidiary Contera Pharma is poised to speed ongoing multinational Phase II...